Fresenius Medical Care Deutschland Gmbh

Medigene Ag

Medigene Oncology Gmbh

Syncore Biotechnology Co., Ltd.

Thomas Fichert

Gerhard Winter

Heinrich Haas

Michael Teifel

Uwe Michaelis

Toralf Peymann

Christian Welz

Carsten Mundus

Friedrich Gruber

Brita Schulze

Oliver Schramel

Thomas Schweitzer

Ingo Bichlmaier

Philippe Laffay

Franz Kugelmann

Michael Herrenbauer

Matthias Brandl

Joern Hoermann

Pascal Mathis

Dominik Fenn

Jörn Hörmann

Johannes Gerber

Jörn HÖRMANN

Method of dissolving/mixing of a concentrate in/with a fluid in a multi-chamber bag and a method for the production of a medical fluid, in particular a dialysis fluid, in a multi-chamber bag. Moreover, the multi-chamber bag itself is disclosed. In all embodiments, at least two different concentrates can be included separately in powder form, liquid form or semi-liquid slurry form for dissolution in a fluid in the multi-chamber bag. In addition, the use of the multi-chamber bag in haemodialysis or peritoneal dialysis or a haemodialysis or peritoneal dialysis device, in particular as a container for a dialysis fluid in a haemodialysis or peritoneal dialysis device, is described.

Multi-chamber bag

The present invention relates to esterified polysaccharide osmotics, use of same, processes for synthesis of same as well as compositions containing same.

Esterified polysaccharide osmotics

The present invention relates to a novel dry concentrate for producing medical solutions, more particularly dialysis solutions, which comprises electrolyte components, buffer components and an osmotic agent, wherein the concentrate comprises magnesium carbonate instead of magnesium chloride. The use of magnesium carbonate as an electrolyte prevents the formation of slurries. By providing anhydrous glucose as an osmotic agent, and by optionally spatially separating this osmotic agent from other components, the occurrence of caking of the concentrate is additionally avoided. The occurrence of caking is further reduced by providing the buffer component sodium bicarbonate together with sodium chloride separate from all other components. The concentrate of the present invention is particularly suitable for use in multi-chamber container bag systems. The concentrate of the present invention exhibits good dissolution behavior and improved storage stability.

Concentrate for medical solutions, production thereof and use thereof in dialysis

A method for producing a cationic liposomal preparation comprising a lipophilic active compound with physical and chemical stability during manufacturing, storing and reconstituting, and further a cationic liposomal preparation obtainable by this method as well as specific cationic liposomal preparations as well as pharmaceutical compositions are disclosed.

Method of producing a cationic liposomal preparation comprising a lipophilic compound

The present invention relates to pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrins as well as their use as osmotic agents, in particular for use in dialysis therapy.

Pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin

Growing community of inventors

Oberthal, Germany

Thomas Fichert